Add Yahoo as a preferred source to see more of our stories on Google. The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and ...
A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...
A risk score based on four factors — male sex, tumor size, World Health Organization (WHO) grade, and lymphovascular invasion — predicts recurrence in patients with node-negative pancreatic ...
Genetic assays have transformed how clinicians approach treatment decisions in breast cancer, offering both predictive and ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
A newly developed MRI-based scoring system may help identify patients at higher risk of early recurrence after surgical ...
Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly ...
In this meta-analysis, researchers aimed to characterize the relationship between sentinel node biopsy and melanoma survival.
Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern Mediterranean Breast cancer imposes a substantial disease burden ...
A new risk score can help predict whether a pancreatic cancer survivor will suffer a recurrence of cancer The 13-point risk score can help doctors more closely monitor patients at higher risk About 10 ...
Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results